Select Medical (NYSE:SEM) Receives Buy Rating from Benchmark

Benchmark reaffirmed their buy rating on shares of Select Medical (NYSE:SEM) in a research report released on Friday, Benzinga reports. Benchmark currently has a $39.00 price objective on the health services provider’s stock.

Separately, StockNews.com upgraded Select Medical from a hold rating to a buy rating in a research note on Friday, March 22nd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of Moderate Buy and a consensus target price of $34.40.

Select Medical Stock Down 1.7 %

NYSE:SEM opened at $27.57 on Friday. The company has a debt-to-equity ratio of 2.32, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $3.54 billion, a PE ratio of 14.45, a PEG ratio of 1.10 and a beta of 1.37. Select Medical has a 52-week low of $21.28 and a 52-week high of $33.51. The stock has a 50-day simple moving average of $28.08 and a 200 day simple moving average of $25.57.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Friday, February 23rd. The health services provider reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. Select Medical had a return on equity of 16.93% and a net margin of 3.65%. Select Medical’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period last year, the company earned $0.22 earnings per share. On average, sell-side analysts expect that Select Medical will post 2.03 EPS for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 13th. Stockholders of record on Friday, March 1st were paid a dividend of $0.125 per share. The ex-dividend date was Thursday, February 29th. This represents a $0.50 annualized dividend and a dividend yield of 1.81%. Select Medical’s dividend payout ratio is currently 26.18%.

Insider Transactions at Select Medical

In related news, Chairman Robert A. Ortenzio sold 50,000 shares of the business’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $26.00, for a total value of $1,300,000.00. Following the completion of the sale, the chairman now directly owns 6,789,668 shares in the company, valued at approximately $176,531,368. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 17.50% of the stock is currently owned by corporate insiders.

Institutional Trading of Select Medical

Hedge funds and other institutional investors have recently bought and sold shares of the business. Quarry LP acquired a new position in shares of Select Medical during the 2nd quarter worth approximately $30,000. Avior Wealth Management LLC acquired a new position in shares of Select Medical during the 3rd quarter worth approximately $25,000. Mitsubishi UFJ Trust & Banking Corp acquired a new position in shares of Select Medical during the 3rd quarter worth approximately $29,000. Geneos Wealth Management Inc. acquired a new position in shares of Select Medical during the 3rd quarter worth approximately $30,000. Finally, GAMMA Investing LLC acquired a new position in shares of Select Medical during the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.